IDiyas

For the Inventor, By the Inventor

Mount Royal, Canada

Francesco Bellini

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 131(Granted Patents)


Location History:

  • St. Laurent, CA (1980)
  • Mt. Royal, CA (1986)
  • Mount Royal, CA (1981 - 1990)

Company Filing History:

goldMedal12 out of 117 
 
Ayerst, Mckenna & Harrison, Inc.
 patents
silverMedal4 out of 1,567 
 
American Home Products Corporation
 patents

Years Active: 1980-1990

Loading Chart...
16 patents (USPTO):Explore Patents
1. 4946987 - N-naphthoylglycine derivatives (1990-08-07),
2. 4705882 - N-naphthoylglycine derivatives (1987-11-10),
3. 4672058 - N[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl]-N (1987-06-09),
4. 4604406 - N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their (1986-08-05),
5. 4600724 - N-naphthoylglycine derivatives (1986-07-15),
6. 4568693 - N-Naphthoylglycine derivatives (1986-02-04),
7. 4547516 - Antisecretory agents derived from meldrum's acid (1985-10-15),
8. 4499310 - 5-Methyl-1-(trifluoromethyl)-2-naphthalenol, process for its preparation (1985-02-12),
9. 4446150 - Naphthalenylthiazole derivatives (1984-05-01),
10. 4439617 - N-Naphthoylglycine derivatives (1984-03-27),
11. 4408077 - 6-(Lower alkoxy)-5-(trifluoromethyl)-1-naphthalenecarboxaldehydes (1983-10-04),
12. 4391825 - N-[[6-(Lower (1983-07-05),
13. 4391816 - N-(Naphthalenylthioxomethyl)aminoacid derivatives (1983-07-05),
14. 4301066 - Preparation of (D-Trp .sup.6)-LH-RH via the heptapeptide (1981-11-17),
15. 4244947 - Carba decapeptide derivatives of [TYR.sup.6 ]-somatostatin (1981-01-13),

Title: The Innovations of Francesco Bellini

Introduction

Francesco Bellini is a notable inventor based in Mount Royal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address diabetic complications. With a total of 16 patents to his name, Bellini's work has had a profound impact on medical science.

Latest Patents

Among his latest innovations are the N-naphthoylglycine derivatives. These derivatives are disclosed as having aldose reductase inhibiting activity, which is crucial for treating diabetic complications. The repeated emphasis on these derivatives highlights their importance in Bellini's research and their potential benefits for patients suffering from diabetes.

Career Highlights

Throughout his career, Bellini has worked with several prominent companies, including Ayerst, McKenna & Harrison, Inc. and American Home Products Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Bellini has collaborated with notable professionals in his field, including Kazimir Sestanj and Nedumparambil A Abraham. These partnerships have likely enriched his work and expanded the scope of his inventions.

Conclusion

Francesco Bellini's contributions to the field of pharmaceuticals through his innovative patents and collaborations have established him as a significant figure in medical research. His work continues to influence the treatment of diabetic complications, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…